We believe that a substantial number of Ozempic lawsuits will be filed in New Jersey state court, in addition to the cases being filed in federal court
If you've tried diet and exercise without sustainable results or you're researching GLP-1 medications, metabolic peptides, or body-composition therapies a single consultation can clarify which path actually fits your physiology, your medical history, and your goals
The medication itself continues binding to receptors and producing its effects
These results are comparable to international GLP-1 agonist data, though the Asian study population and BMI cutoffs limit direct comparisons to global datasets
Mild side effects like nausea and gastrointestinal issues are common with semaglutide
Sources Eldor, R., Avraham, N., Rosenberg, O., Shpigelman, M., Golan-Cohen, A., Cukierman-Yaffe, T., Merzon, E., & Buch, A